SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is a major talking point following a significant price retracement that has sharply divided the crypto community. Many express bearish views, labeling it a "scam" or "worthless" and suggesting a flight to gold and silver, with some attributing the drop to institutional selling and leveraged long liquidations. In contrast, staunch bulls are framing the current dip as a "bear trap" and a compelling "buy opportunity," maintaining confidence in a future rebound.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is trending due to an intensifying Arctic blast and widespread winter storm across the U.S., which is significantly increasing natural gas demand for heating and electricity. The community is actively discussing the potential for further price movements, balancing immediate demand surges and possible production freeze-offs against concerns about power outages reducing consumption and the inherent volatility of natural gas markets.

SSgA Active Trust - SPDR S&P 500 ETF Trust

Conversations around SPY are intensely focused on a potential government shutdown and recent tariff threats, creating significant market uncertainty. Community discussions are split between strong bearish predictions for a market pullback and contrarian views anticipating resilience, especially with upcoming major tech earnings. Amidst these factors, precious metals like gold and silver are gaining attention as they reach new highs, reflecting broader concerns about market stability.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending due to reports of a substantial U.S. government investment, including a 10% equity stake and debt financing, aimed at bolstering domestic critical mineral supply chains. The community is highly bullish, anticipating significant price appreciation and potential short squeezes, drawing comparisons to past government-backed plays in the rare earth sector. This strategic backing underscores the company's crucial role in national security and the broader push to secure essential materials for high-tech industries.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

ProShares UltraShort Bloomberg Natural Gas (KOLD) is trending amid extreme volatility in natural gas markets, fueled by severe winter weather across the U.S. and discussions around potential production impacts and LNG export changes. The community is sharply divided, debating whether the current cold snap and its effects are already priced into natural gas, leading to intense speculation on KOLD's rebound against its inverse counterpart, BOIL, or if further downside is expected.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics (CVKD) is drawing significant attention following progress in Tecarfarin's manufacturing and new research emphasizing its potential for LVAD patients, complemented by a strategic pipeline acquisition. The community is actively debating its future as a novel anticoagulant with FDA designations and an Abbott collaboration, contrasting this optimism with concerns over financing and perceived promotional activity.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust ($SLV) is experiencing a historic surge, driven by reports of record silver prices in Asian markets and China's new export restrictions, exacerbating an existing physical shortage. The community is actively discussing the end of decades-long price suppression, with many believing a massive short squeeze is underway, fueled by strong industrial demand from sectors like EVs and AI, and a flight of capital from crypto into tangible assets amidst broader global financial uncertainty. While some traders warn of an unsustainable "overbought" bubble, the dominant sentiment points to significantly higher prices as silver revalues.

United States Commodity Funds LLC - United States Natural Gas Fund

United States Natural Gas Fund, LP

UNG is experiencing extreme volatility as a severe winter storm across the U.S. drives an unprecedented surge in natural gas demand and prices. The community is sharply divided, with many expecting continued gains due to the intense cold, while others caution that the rally is overextended and "priced in," anticipating a significant pullback. This high-stakes environment reflects natural gas's reputation as a "widowmaker" among traders.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

The biotech sector, represented by LABU, is experiencing robust upward momentum, largely driven by market optimism surrounding potential Federal Reserve rate cuts and the transformative impact of AI on drug discovery. This rally is further amplified by ongoing significant buyout activities within the sector, sparking widespread community discussion about a substantial recovery and capital rotation into biotech, despite some expressing caution regarding its rapid ascent.

Sumitomo Mitsui Financial Group, Inc. operates as a holding company, which engages in the management of its subsidiaries that provide financial services. It operates through the following segments: Wholesale, Retail, Global, Market and Head Office Management. The Wholesale Business segment dealings with domestic large corporations and small and medium-sized enterprises. The Retail Business segment dealings with domestic individual customers. The Global Business segment dealings with overseas Japanese and non-Japanese companies. The Market Business segment operations related to financial markets. The Head Office Management segment that does not belong to any of the above business divisions. The company was founded on December 2, 2002 and is headquartered in Tokyo, Japan.

Sumitomo Mitsui Financial Group Inc - ADR

Sumitomo Mitsui Financial Group Inc (Ads)

Sumitomo Mitsui Financial Group is trending amid robust financial results, including record profits and strong earnings forecasts, along with shareholder return initiatives like share buybacks and enhanced dividends. The community is also closely watching the Bank of Japan's evolving monetary policy, anticipating further interest rate increases expected to significantly benefit Japanese mega-banks. Additionally, prominent investor interest in the Japanese financial sector, notably from Warren Buffett, continues to draw attention to the group's long-term stability and value.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

WST Launches Synchrony S1 Prefillable Syringe at Pharmapack

West Pharmaceutical debuts the Synchrony S1 prefillable syringe at Pharmapack 2026, enhancing biologics, vaccines and home-care support.

Here's Why You Should Retain Integer Holdings Stock in Your Portfolio

ITGR leans on R&D and MedTech scale after a solid Q3 2025, but slower product adoption and supplier reliance cloud the near-term outlook.

BD and Ypsomed Expand Partnership to Target Growing Biologics Market

BDX expands its Ypsomed partnership with a 5.5 mL Neopak XtraFlow syringe, targeting rising demand for large-volume subcutaneous self-injection.

Rakuten Investment Management Inc. Acquires New Position in The Cooper Companies, Inc. $COO

Rakuten Investment Management Inc. bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the third quarter, according to the company in its most recent 13F...

BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System

BDX wins FDA 510(k) clearance for the EnCor EnCompass breast biopsy system, set for an early 2026 launch to boost flexibility and patient care.

The Cooper Companies, Inc. $COO Shares Acquired by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA lifted its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 96.9% during the third quarter, according to its most recent 13F filing with the...

The Cooper Companies, Inc. (NASDAQ:COO) Given Average Rating of "Moderate Buy" by Brokerages

The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) has earned a consensus rating of "Moderate Buy" from the sixteen brokerages that are covering the company, MarketBeat reports. One equities...

Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of The Cooper Companies, Inc. (NASDAQ:COO). In a filing disclosed on January 12th, the Representative disclosed that...

Reasons to Add West Pharmaceutical Stock to Your Portfolio Now

WST is riding on surging GLP-1 demand and HVP expansion. Yet, pricing pressure, tariff risks and contract manufacturing headwinds cloud the near-term outlook.

COO or WST: Which Is the Better Value Stock Right Now?

COO vs. WST: Which Stock Is the Better Value Option?

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Cooper Companies, Inc.

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

Current Price	$81.29
Prev Close	$82.80
Open	$82.27
Dividend Yield	0.00%
50-Day Moving Average	$79.51
Beta	0.79
Avg. Volume	3.22M
PE Ratio	43.38

52-Week High	$100.24
52-Week Low	$61.78
Market Capitalization	$16.29B
EPS (Annual)	$1.87
Price to Book	1.93
Revenue Per Employee	$272,826.67
Enterprise Value/EBITDA	N/A

COO
Cooper Companies, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest COO News

COOCooper Companies, Inc.